| Generic. | |
| Cr | Chromium |
| DHA | Docosahexaenoic acid |
| DM | Diabetes mellitus |
| GLP-1 | Glucagon-like peptide-1 |
| HbA1c | Glycosylated hemoglobin |
| PUFAs | Polyunsaturated fatty acids |
| BGL | Blood glucose levels |
| COMT | Catechol-O-methyltransferase |
| FI | Food intake |
| FO | Fat oxidation |
| GL | Glucose levels |
| GLUT4 | Glucose transporter 4 |
| GU | Glucose uptake |
| HOMA-IR | Homeostatic model assessment of insulin resistance index |
| LKB1/AMP | Liver kinase B1/adenosine monophosphate activated protein kinase |
| NF-Κb | Nuclear factor κB |
| Nrf2 | Nuclear factor erythroid 2–related factor 2 |
| OS | Oxidative stress |
| PPAR | Peroxisome proliferator-activated receptors |
| QUICKI | Quantitative insulin sensitivity check index |
| RMR | Resting metabolic rate |
| ROS | Reactive oxygen species |
| SAA | Serum amyloid plasma |
| SE | Sensivity |
| VLDL-C | Very low-density lipoprotein cholesterol |
| Applications. | |
| CF | Commercial formulations |
| DS | Dietary supplementation |
| FI | Food ingredient |
| PR | Preservative |
| TP | Technological properties |
| Bioactivities. | |
| AA | Anti-aging |
| AD | Anti-diabetic |
| AG | α-amylase and α-glucosidase inhibition |
| AH | Anti-hypertensive |
| AI | Anti-inflammatory |
| AM | Antimicrobial |
| AO | Antioxidant activity |
| CP | Cardiovascular protection |
| MM | Microbiota modulation |
| OB | Anti-obesity |
| SA | Satiating |
| Compounds. | |
| AA | Arachidonic acids |
| AAs | Amino acids |
| AGEs | Advanced glycation end products |
| ALA | Alpha-lipoic acid |
| Chl | Cholesterol |
| Cr | Chromium |
| Cur | Curcumin |
| Cys | Cystine |
| Dapa | Dapagliflozin |
| DHA | Docosahexaenoic acid |
| EAA | Essential amino acids |
| EC | Epicatechin |
| ECG | Epicatechin gallate |
| EGC | Epigallocatechin |
| EGCG | Epigallocatechin gallate |
| EPA | Eicosapentaenoic acid |
| FA | Fatty acids |
| GLP-1 | Glucagon-like peptide-1 |
| HbA1c | Glycosylated hemoglobin |
| Met | Metformin |
| N.S. | Not specified |
| Pio | Pioglitazone |
| PUFAs | Polyunsaturated fatty acids |
| Tyr | Tyrosine |
| Diseases. | |
| CHD | Coronary heart disease |
| NPDR | Non-proliferative diabetic retinopathy |
| T2DM | Type 2 diabetic mellitus |
| Extraction. | |
| DE | Decoction |
| EAE | Enzyme-assisted extraction |
| MA | Maceration |
| SE | Solvent extraction |
| UAE | Ultrasound-assisted extraction |
| Solvents. | |
| Acet | Acetone |
| hex | Hexane |
| MetOH | Methanol |
| W | Deionized water |
| Study. | |
| DB | Double-blind controlled study |
| DBPC RCT | Double-blind placebo-controlled randomized controlled trial |
| n | Number of individuals |
| PS | Prospective study |
| RCT | Single-blind, placebo-controlled trial |
| RCT | Randomized controlled trial |